• Androgen Receptor and ARv7 in TNBC: Prognostic Role and EPI-

  2026-07-27

  This study systematically investigates the prognostic impact of androgen receptor (AR) and its variant ARv7 in triple-negative breast cancer (TNBC) patients, revealing their association with poor survival and increased metastasis. Functional experiments demonstrate that targeting AR and ARv7—including via the N-terminal domain inhibitor EPI-001—modulates key metastatic and epithelial–mesenchymal transition (EMT) pathways in TNBC models, highlighting new directions for targeted research.

• Ruxolitinib (INCB018424): Optimizing JAK-STAT Assays in Rese

  2026-07-27

  Ruxolitinib (INCB018424) stands out as a highly selective JAK1/2 inhibitor, enabling reliable modulation of JAK-STAT signaling in myeloproliferative disorder and immuno-oncology research. This article translates advanced spectral flow cytometry and immune profiling workflows into actionable protocols, with troubleshooting tips grounded in recent high-dimensional assay innovation.

• Annular Sector Microneedle Enables Targeted Mitochondrial Th

  2026-07-26

  The referenced study introduces a novel annular sector-shaped microneedle for localized co-delivery of Nmnat1 gene-loaded lipid nanoparticles and nicotinamide to the trabecular meshwork in glaucoma. This approach synergistically restores mitochondrial function and reduces intraocular pressure, marking a significant advance in targeted ocular gene therapy.

• Atomic Structure of ASC-Mediated Inflammasome Assembly Decod

  2026-07-25

  This study provides the first atomic-resolution insight into how full-length ASC proteins organize inflammasomes, revealing multitrack filament bundles and their role in Caspase-1 activation. These findings clarify the molecular mechanisms underlying inflammasome assembly and have important implications for apoptosis and inflammatory disease research.

• ALDOB K87 Lactylation Regulates Mitochondrial Dynamics in PH

  2026-07-24

  Yi et al. (2026) identify lysine-87 lactylation of aldolase B (ALDOB) as a pivotal driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). This mechanistic insight connects metabolic alterations to pathological smooth muscle cell behavior, opening new research pathways for targeting vascular remodeling in PH.

• Enhancing Panobinostat Efficacy in Myeloma via PDI Inhibitio

  2026-07-24

  This article examines a recent study demonstrating how the PDI inhibitor LTI6426 significantly boosts the efficacy of panobinostat in preclinical multiple myeloma models, even in cases resistant to proteasome inhibition. The work highlights mechanistic convergence on ER stress signaling and suggests new avenues for safer, more effective combination regimens in myeloma research.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Mechanistic

  2026-07-23

  Wang et al. (2018) provide mechanistic clarity on how type III grass carp reovirus (GCRV104) enters host cells, revealing a reliance on clathrin-mediated endocytosis and dynamin-dependent, pH-sensitive uptake. These findings refine our understanding of viral entry in aquaculture pathogens and offer a strategic framework for inhibitor-based research and therapeutic development.

• Angiotensin (1-7): Applied Research Protocols and Innovation

  2026-07-23

  Harness Angiotensin (1-7)'s multi-domain potential with validated protocols, troubleshooting insight, and recent mechanistic breakthroughs. This article bridges high-purity APExBIO supply with strategic workflow guidance for researchers targeting fibrosis, metabolism, and emerging viral mechanisms.

• Flumequine: Precision DNA Topoisomerase II Inhibition in Res

  2026-07-22

  Flumequine stands out as a robust DNA topoisomerase II inhibitor, enabling precise, reproducible control of DNA replication and drug response assays. This article delivers actionable insights on experimental design, workflow optimization, and troubleshooting to maximize the value of Flumequine in advanced DNA replication research and cancer biology studies.

• Flumequine: Strategic Leverage in DNA Topoisomerase II Resea

  2026-07-22

  Explore how Flumequine, a selective DNA topoisomerase II inhibitor, is reshaping translational research strategies. This article blends mechanistic insight with actionable protocol guidance and strategic positioning, drawing on recent advances in in vitro drug response evaluation and competitive benchmarking. Anchored by the latest systems biology frameworks, it offers translational scientists a forward-thinking roadmap for DNA replication, repair, and cancer drug discovery.

• Isorhamnetin: Advanced Insights for Signaling and Oocyte Hea

  2026-07-21

  Explore the multifaceted role of Isorhamnetin in modulating cell signaling pathways and protecting oocyte health. This in-depth article reveals advanced mechanistic insights and practical assay guidance, setting it apart from existing coverage.

• Gut-Brain Cholinergic Signaling in Antiseizure Therapy: New

  2026-07-21

  Jia et al. reveal that Bacteroides fragilis exerts antiseizure effects by enhancing cholinergic signaling along the gut-vagus-brain axis. This discovery clarifies a mechanistic connection between intestinal microbiota composition and neuronal excitability, informing translational strategies for refractory epilepsy.

• Dacomitinib (PF-00299804): Pan-HER Inhibitor in Cancer Resea

  2026-07-20

  Dacomitinib (PF-00299804) is a potent irreversible inhibitor of EGFR, HER2, and HER4, showing efficacy in models resistant to standard therapies. It induces cell cycle arrest and apoptosis in cancer cells. Its well-characterized solubility and storage properties support robust experimental design.

• CAY10499: Potent Inhibitor of Human Hormone Sensitive Lipase

  2026-07-20

  CAY10499 is a crystalline inhibitor of human hormone sensitive lipase (HSL) and monoglyceride lipase (MGL), enabling precise dissection of lipid metabolism in research. It exhibits nanomolar potency, high selectivity, and is recommended for advanced lipid metabolism and immunometabolic studies.

• 3X (DYKDDDDK) Peptide: Precision Tool for Protein Purificati

  2026-07-19

  The 3X (DYKDDDDK) Peptide stands out for its trimeric epitope sequence, delivering superior specificity and yield in affinity purification and immunodetection of FLAG-tagged proteins. Its proven compatibility with structural, biochemical, and metal-sensitive assays makes it a gold-standard tag for advanced recombinant protein workflows.

15726 records 1/1049 page Next 12345 下5页 Last page